Kestrel Therapeutics
BiotechnologyView the employees at
Kestrel Therapeutics-
Scott L Cohen Head of Program Management at Kestrel Therapeutics
-
Greater Boston
-
Top 10%
Dilinie Fernando Sr. Scientist II at Kestrel Therapeutics-
Cambridge, Massachusetts, United States
-
Top 10%
Overview
Our goal is to bring new therapy to cancer’s most frequently mutated oncogenic target. Kestrel is discovering and developing new molecules to treat intractable cancers. We are starting with potent inhibitors of pan-oncogenic-RAS. We rely on exceptional science, and our focus, always, is on patients.
-